Results 151 to 160 of about 268,751 (268)

Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma. [PDF]

open access: yesBlood Adv
Meriranta L   +14 more
europepmc   +1 more source

Allogeneic transplantation for mantle cell lymphoma [PDF]

open access: hybrid, 2004
Isabelle Bence‐Bruckler   +9 more
openalex   +1 more source

Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects

open access: yesBritish Journal of Haematology, 2018
O. Hershkovitz-Rokah   +3 more
semanticscholar   +1 more source

Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma [PDF]

open access: bronze, 2005
Mathias Rummel   +14 more
openalex   +1 more source

Chemotherapy with rituximab followed by high‐dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma [PDF]

open access: bronze, 2005
Catherine Thiéblemont   +11 more
openalex   +1 more source

Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open‐label studies

open access: yesBritish Journal of Haematology, 2017
S. Rule   +14 more
semanticscholar   +1 more source

Disease management landscape in patients with mantle cell lymphoma in Japan: a real-world study. [PDF]

open access: yesFuture Oncol
Rai S   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy